AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,940,635 | -12.6% | 1,573,359 | +0.0% | 0.47% | -3.1% |
| Q2 2023 | $44,554,553 | +24.5% | 1,573,254 | +1.0% | 0.49% | +20.1% |
| Q1 2023 | $35,780,484 | -11.6% | 1,557,705 | +8.1% | 0.41% | -15.7% |
| Q4 2022 | $40,462,887 | +3.7% | 1,440,986 | +4.4% | 0.48% | +0.8% |
| Q3 2022 | $39,037,000 | +27.8% | 1,380,389 | +0.2% | 0.48% | +36.9% |
| Q2 2022 | $30,545,000 | -19.0% | 1,377,780 | +6.3% | 0.35% | +6.1% |
| Q1 2022 | $37,725,000 | -12.5% | 1,295,948 | -1.2% | 0.33% | -4.6% |
| Q4 2021 | $43,131,000 | -13.5% | 1,312,164 | +21.5% | 0.35% | -11.3% |
| Q3 2021 | $49,856,000 | -12.5% | 1,080,309 | +4.5% | 0.39% | -9.1% |
| Q2 2021 | $56,952,000 | -1.5% | 1,033,431 | -7.7% | 0.43% | -0.7% |
| Q1 2021 | $57,814,000 | +14.2% | 1,119,566 | -4.1% | 0.43% | +10.2% |
| Q4 2020 | $50,607,000 | +33.7% | 1,167,935 | +8.0% | 0.39% | +8.6% |
| Q3 2020 | $37,864,000 | -34.5% | 1,081,824 | +0.1% | 0.36% | -39.5% |
| Q2 2020 | $57,804,000 | +47.0% | 1,080,854 | -2.5% | 0.60% | +15.7% |
| Q1 2020 | $39,320,000 | -25.7% | 1,108,241 | -0.0% | 0.52% | +9.6% |
| Q4 2019 | $52,926,000 | +57.2% | 1,108,401 | +6.7% | 0.47% | +40.2% |
| Q3 2019 | $33,666,000 | -17.9% | 1,039,075 | +26.5% | 0.34% | -14.7% |
| Q2 2019 | $40,987,000 | -17.6% | 821,716 | +11.4% | 0.39% | -16.0% |
| Q1 2019 | $49,764,000 | +58.3% | 737,896 | +8.2% | 0.47% | +42.1% |
| Q4 2018 | $31,438,000 | -37.2% | 681,803 | +5.1% | 0.33% | -21.2% |
| Q3 2018 | $50,024,000 | +7.1% | 648,656 | +17.0% | 0.42% | -2.1% |
| Q2 2018 | $46,686,000 | -0.2% | 554,264 | -3.1% | 0.43% | -8.4% |
| Q1 2018 | $46,771,000 | +491.3% | 571,914 | +313.3% | 0.47% | +483.8% |
| Q4 2017 | $7,910,000 | -14.4% | 138,368 | 0.0% | 0.08% | -23.8% |
| Q3 2017 | $9,236,000 | +42.4% | 138,368 | +9.8% | 0.10% | +31.2% |
| Q2 2017 | $6,486,000 | -11.9% | 126,062 | 0.0% | 0.08% | -20.0% |
| Q1 2017 | $7,362,000 | +177.8% | 126,062 | +98.5% | 0.10% | +138.1% |
| Q4 2016 | $2,650,000 | -41.3% | 63,507 | -25.6% | 0.04% | -48.8% |
| Q3 2016 | $4,511,000 | +26.1% | 85,405 | 0.0% | 0.08% | +13.9% |
| Q2 2016 | $3,578,000 | +45.9% | 85,405 | +41.4% | 0.07% | +33.3% |
| Q1 2016 | $2,452,000 | -37.5% | 60,405 | 0.0% | 0.05% | -49.5% |
| Q4 2015 | $3,921,000 | +756.1% | 60,405 | +504.0% | 0.11% | +723.1% |
| Q2 2014 | $458,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |